These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25849606)

  • 1. Functional characterization of putative novel splicing mutations in the cardiomyopathy-causing genes.
    Millat G; Lafont E; Nony S; Rouvet I; Bozon D
    DNA Cell Biol; 2015 Jul; 34(7):489-96. PubMed ID: 25849606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Studies and In Silico Analyses to Evaluate Non-Coding Variants in Inherited Cardiomyopathies.
    Frisso G; Detta N; Coppola P; Mazzaccara C; Pricolo MR; D'Onofrio A; Limongelli G; Calabrò R; Salvatore F
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key Value of RNA Analysis of MYBPC3 Splice-Site Variants in Hypertrophic Cardiomyopathy.
    Singer ES; Ingles J; Semsarian C; Bagnall RD
    Circ Genom Precis Med; 2019 Jan; 12(1):e002368. PubMed ID: 30645170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole MYBPC3 NGS sequencing as a molecular strategy to improve the efficiency of molecular diagnosis of patients with hypertrophic cardiomyopathy.
    Janin A; Chanavat V; Rollat-Farnier PA; Bardel C; Nguyen K; Chevalier P; Eicher JC; Faivre L; Piard J; Albert E; Nony S; Millat G
    Hum Mutat; 2020 Feb; 41(2):465-475. PubMed ID: 31730716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micro-exons of the cardiac myosin binding protein C gene: flanking introns contain a disproportionately large number of hypertrophic cardiomyopathy mutations.
    Frank-Hansen R; Page SP; Syrris P; McKenna WJ; Christiansen M; Andersen PS
    Eur J Hum Genet; 2008 Sep; 16(9):1062-9. PubMed ID: 18337725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Troponin T (TNNT2) mutations are less prevalent in Indian hypertrophic cardiomyopathy patients.
    Rani DS; Nallari P; Dhandapany PS; Tamilarasi S; Shah A; Archana V; AshokKumar M; Narasimhan C; Singh L; Thangaraj K
    DNA Cell Biol; 2012 Apr; 31(4):616-24. PubMed ID: 22017532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation screening of TNNT2 gene in a cohort of patients with hypertrophic and dilated cardiomyopathy.
    Jáchymová M; Muravská A; Paleček T; Kuchynka P; Řeháková H; Magage S; Král A; Zima T; Horký K; Linhart A
    Physiol Res; 2012; 61(2):169-75. PubMed ID: 22292720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
    Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
    Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.
    Marsiglia JD; Credidio FL; de Oliveira TG; Reis RF; Antunes Mde O; de Araujo AQ; Pedrosa RP; Barbosa-Ferreira JM; Mady C; Krieger JE; Arteaga-Fernandez E; Pereira Ada C
    Am Heart J; 2013 Oct; 166(4):775-82. PubMed ID: 24093860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of large gene deletions and duplications in MYBPC3 and TNNT2 in patients with hypertrophic cardiomyopathy.
    Bagnall RD; Yeates L; Semsarian C
    Int J Cardiol; 2010 Nov; 145(1):150-3. PubMed ID: 19666196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of pathogenic gene mutations in
    Ito K; Patel PN; Gorham JM; McDonough B; DePalma SR; Adler EE; Lam L; MacRae CA; Mohiuddin SM; Fatkin D; Seidman CE; Seidman JG
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7689-7694. PubMed ID: 28679633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splicing analysis of 26 F8 nucleotide variations using a minigene assay.
    Jourdy Y; Fretigny M; Nougier C; Négrier C; Bozon D; Vinciguerra C
    Haemophilia; 2019 Mar; 25(2):306-315. PubMed ID: 30690819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of mutations causing hypertrophic cardiomyopathy in a group of patients from Espirito Santo, Brazil].
    Marsiglia JD; Batitucci Mdo C; Paula Fd; Barbirato C; Arteaga E; Araújo AQ
    Arq Bras Cardiol; 2010 Jan; 94(1):10-7. PubMed ID: 20414521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of a large MYBPC3 rearrangement in a cohort of 100 unrelated patients with hypertrophic cardiomyopathy.
    Chanavat V; Seronde MF; Bouvagnet P; Chevalier P; Rousson R; Millat G
    Eur J Med Genet; 2012 Mar; 55(3):163-6. PubMed ID: 22314326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of two novel splicing mutations in the OCA2 gene associated with oculocutaneous albinism type II.
    Rimoldi V; Straniero L; Asselta R; Mauri L; Manfredini E; Penco S; Gesu GP; Del Longo A; Piozzi E; Soldà G; Primignani P
    Gene; 2014 Mar; 537(1):79-84. PubMed ID: 24361966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of high-throughput targeted exome-sequencing to screen for copy number variation in hypertrophic cardiomyopathy.
    Lopes LR; Murphy C; Syrris P; Dalageorgou C; McKenna WJ; Elliott PM; Plagnol V
    Eur J Med Genet; 2015 Nov; 58(11):611-6. PubMed ID: 26455666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene.
    Bonnet C; Krieger S; Vezain M; Rousselin A; Tournier I; Martins A; Berthet P; Chevrier A; Dugast C; Layet V; Rossi A; Lidereau R; Frébourg T; Hardouin A; Tosi M
    J Med Genet; 2008 Jul; 45(7):438-46. PubMed ID: 18424508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted next-generation sequencing (NGS) of nine candidate genes with custom AmpliSeq in patients and a cardiomyopathy risk group.
    Glotov AS; Kazakov SV; Zhukova EA; Alexandrov AV; Glotov OS; Pakin VS; Danilova MM; Poliakova IV; Niyazova SS; Chakova NN; Komissarova SM; Kurnikova EA; Sarana AM; Sherbak SG; Sergushichev AA; Shalyto AA; Baranov VS
    Clin Chim Acta; 2015 Jun; 446():132-40. PubMed ID: 25892673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mutations in genes for sarcomeric proteins].
    Kimura A
    Nihon Rinsho; 2000 Jan; 58(1):117-22. PubMed ID: 10885298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.